Globus Medical Stock Rises First Day as Publicly Traded Company

Stocks of Globus Medical rose 13 percent on its first day as a publicly traded company, according to a Wall Street Journal report.

Advertisement

Globus’ initial public offering reaped $100 million. The company’s initial offering price — $12 on the New York Stock Exchange — rose to $13.10 and then closed at $13.50 at then end of the session.

More Articles on Orthopedic Devices:

Bioimplants Market to Reach $134B

Judge Rejects Orthofix’s Settlement Over Medicare Fraud Case

DePuy Wins Patent for Spine Cage Instruments

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.